These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33086123)

  • 1. Nitric oxide (NO) and nanoparticles - Potential small tools for the war against COVID-19 and other human coronavirus infections.
    Pieretti JC; Rubilar O; Weller RB; Tortella GR; Seabra AB
    Virus Res; 2021 Jan; 291():198202. PubMed ID: 33086123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric Oxide to Fight Viral Infections.
    Lisi F; Zelikin AN; Chandrawati R
    Adv Sci (Weinh); 2021 Apr; 8(7):2003895. PubMed ID: 33850691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Could nasal nitric oxide help to mitigate the severity of COVID-19?
    Martel J; Ko YF; Young JD; Ojcius DM
    Microbes Infect; 2020; 22(4-5):168-171. PubMed ID: 32387333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of NO in COVID-19 and potential therapeutic strategies.
    Fang W; Jiang J; Su L; Shu T; Liu H; Lai S; Ghiladi RA; Wang J
    Free Radic Biol Med; 2021 Feb; 163():153-162. PubMed ID: 33347987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia.
    Zhang H; Zhang C; Hua W; Chen J
    Med Gas Res; 2024; 14(2):39-47. PubMed ID: 37929506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia.
    Safaee Fakhr B; Di Fenza R; Gianni S; Wiegand SB; Miyazaki Y; Araujo Morais CC; Gibson LE; Chang MG; Mueller AL; Rodriguez-Lopez JM; Ackman JB; Arora P; Scott LK; Bloch DB; Zapol WM; Carroll RW; Ichinose F; Berra L;
    Nitric Oxide; 2021 Nov; 116():7-13. PubMed ID: 34400339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of nanomaterials in treatment, anti-infection and detection of coronaviruses.
    Nikaeen G; Abbaszadeh S; Yousefinejad S
    Nanomedicine (Lond); 2020 Jun; 15(15):1501-1512. PubMed ID: 32378459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension.
    Feng WX; Yang Y; Wen J; Liu YX; Liu L; Feng C
    ESC Heart Fail; 2021 Feb; 8(1):714-718. PubMed ID: 33205620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients.
    Parikh R; Wilson C; Weinberg J; Gavin D; Murphy J; Reardon CC
    Ther Adv Respir Dis; 2020; 14():1753466620933510. PubMed ID: 32539647
    [No Abstract]   [Full Text] [Related]  

  • 12. The broad-spectrum antiviral recommendations for drug discovery against COVID-19.
    Hazafa A; Ur-Rahman K; Haq IU; Jahan N; Mumtaz M; Farman M; Naeem H; Abbas F; Naeem M; Sadiqa S; Bano S
    Drug Metab Rev; 2020 Aug; 52(3):408-424. PubMed ID: 32546018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2.
    Lisi L; Lacal PM; Barbaccia ML; Graziani G
    Biochem Pharmacol; 2020 Oct; 180():114169. PubMed ID: 32710969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Concentrations of Nitric Oxide Inhalation Therapy in Pregnant Patients With Severe Coronavirus Disease 2019 (COVID-19).
    Safaee Fakhr B; Wiegand SB; Pinciroli R; Gianni S; Morais CCA; Ikeda T; Miyazaki Y; Marutani E; Di Fenza R; Larson GM; Parcha V; Gibson LE; Chang MG; Arora P; Carroll RW; Kacmarek RM; Ichinose F; Barth WH; Kaimal A; Hohmann EL; Zapol WM; Berra L
    Obstet Gynecol; 2020 Dec; 136(6):1109-1113. PubMed ID: 32852324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I IFNs: A Blessing in Disguise or Partner in Crime in MERS-CoV-, SARS-CoV-, and SARS-CoV-2-Induced Pathology and Potential Use of Type I IFNs in Synergism with IFN-
    Anjum FR; Anam S; Abbas G; Mahmood MS; Rahman SU; Goraya MU; Abdullah RM; Luqman M; Ali A; Akram MK; Chaudhry TH
    Viral Immunol; 2021 Jun; 34(5):321-329. PubMed ID: 33181057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives for the Use of N-acetylcysteine as a Candidate Drug to Treat COVID-19.
    Luo P; Liu Y; Liu D; Li J
    Mini Rev Med Chem; 2021; 21(3):268-272. PubMed ID: 33109047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
    Patil AM; Göthert JR; Khairnar V
    Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Any possible role of phosphodiesterase type 5 inhibitors in the treatment of severe COVID19 infections? A lesson from urology.
    Dal Moro F; Livi U
    Clin Immunol; 2020 May; 214():108414. PubMed ID: 32272196
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood nitrate and nitrite modulating nitric oxide bioavailability: Potential therapeutic functions in COVID-19.
    Yamasaki H
    Nitric Oxide; 2020 Oct; 103():29-30. PubMed ID: 32712272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected Patients.
    Annweiler C; Cao Z; Wu Y; Faucon E; Mouhat S; Kovacic H; Sabatier JM
    Infect Disord Drug Targets; 2020; 20(4):407-408. PubMed ID: 32418532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.